Menstrual Cycle and Contraceptive Status Charting in the Female Athlete Intake: What the Sports RD Should Capture and Why
Most sports nutrition intakes capture menstrual status as a single "regular / irregular" checkbox — and never ask about the contraceptive method. That isn't a clinical record. Here is the chart structure I use for every female-athlete intake, with the eight fields per cycle history, the contraceptive cross-reference, and the SOAP block that makes downstream biomarker interpretation defensible.
Open a typical sports nutrition intake form and find the menstrual-history question. If it exists at all, it almost always reads the same way: "Menstrual status: regular / irregular / N/A." One line. Three radio buttons. The athlete checks "regular" and the chart moves on.\n\nThat is not menstrual-history documentation. It is a checkbox. Documentation — the term the female-athlete clinical literature uses — is the structured process of capturing every relevant cycle variable, identifying the contraceptive method and any hormonal modifiers in use, flagging the cycle history against energy-availability and bone-health risk, and producing a chart entry that makes downstream biomarker interpretation defensible. The output is a chart another sports RD could pick up in three months and read.\n\nThis post is the menstrual-history protocol I run on every female-athlete intake. It takes 5-8 additional minutes per intake. It catches more clinical signal than any other single piece of the female-athlete workup, and it is the chart entry that makes RED-S screening, ferritin interpretation, bone-density referral, and body-composition trending interpretable.\n\n## Why "menstrual status: regular" fails as documentation\n\nFour failure modes show up consistently when the intake captures cycle history as a checkbox:\n\nThe definition of "regular" is undefined. ACOG defines a regular cycle as 21-35 days, lasting 2-7 days, with month-to-month variation under 7-9 days. The athlete defines "regular" as "I get a period sometimes." These are not the same. Without a quantitative definition, the chart entry is athlete-self-assessment, not clinical history.\n\nThe contraceptive method is invisible. Combined oral contraceptives suppress the natural cycle and produce a withdrawal bleed. Progestin-only methods (Depo-Provera, hormonal IUDs, the implant) may produce amenorrhea or irregular spotting. Copper IUDs preserve the natural cycle but increase menstrual blood loss and iron requirements. The chart entry "regular cycle" tells you nothing about which of these realities you are looking at.\n\nFunctional hypothalamic amenorrhea is missed. An athlete on a hormonal contraceptive who would otherwise have stopped cycling will have a withdrawal bleed every month. The chart reads "regular." The athlete is in functional hypothalamic amenorrhea masked by the contraceptive. RED-S risk is high. The bone-health trajectory is poor. None of it is visible without the contraceptive cross-reference.\n\nPhase-aligned nutrition planning isn't possible. Carbohydrate oxidation, protein utilization, fluid retention, and substrate availability all vary across the menstrual cycle in eumenorrheic athletes. An RD planning fuel without knowing the athlete's current cycle phase is planning for an averaged athlete who doesn't exist.\n\nThe gap between "athlete checked the regular box" and "the RD has documented the menstrual history" is the gap between a form field and a clinical record.\n\n## The eight fields per cycle history\n\nFor each female-athlete intake, the chart should capture eight fields:\n\n1. Menarche age. Not "12-ish" — the specific age, or "13y4mo" if the athlete remembers more precisely. Delayed menarche (>15 years) and primary amenorrhea (>16 years) are both clinical flags that change the rest of the workup.\n\n2. Cycle count over the last 12 months. Number of cycles experienced in the last 12 months. An athlete reporting "I've had 7 periods in the last year" is in oligomenorrhea by ACOG criteria. An athlete reporting "I haven't had a period in 4 months" is in secondary amenorrhea (if it has been 3+ consecutive missed cycles). Capture the number, not the adjective.\n\n3. Typical cycle length and variation. Last three cycle lengths in days, plus the inter-cycle variation. "27, 31, 28 days; variation 4 days" tells you cycle length is normal-range and the variation is within normal. "24, 38, 21 days; variation 17 days" tells you the cycles are dysregulated regardless of how the athlete characterizes them.\n\n4. Flow duration and intensity. Days of flow and a subjective intensity ("light / moderate / heavy"). Heavy menstrual bleeding — defined operationally as >7 days or >80 mL — is a separate clinical pathway and a frequent driver of iron-deficiency anemia in female athletes.\n\n5. Current contraceptive method. Specific product. "Combined oral contraceptive — Yaz, 28-day cycle" or "Levonorgestrel IUD — Mirena, 5-year, placed 2024-03" or "None — not currently on any hormonal contraception." Method matters: combined oral contraceptives, the patch, and the ring suppress endogenous cycling; progestin-only pills, Depo-Provera, hormonal IUDs, and the implant produce variable cycle expression; copper IUDs preserve the natural cycle but increase blood loss. The chart entry must name the method, not the category.\n\n6. Duration of current contraceptive use. Start date or duration. An athlete two months into a new oral contraceptive is still equilibrating; an athlete on Depo-Provera for four years is in a different bone-health risk category than one in her first year.\n\n7. Previous contraceptive history. Methods used and discontinued, with rough timeline. The athlete who has cycled through three different oral contraceptives and stopped each one for side effects is a different patient from the athlete on the same method since age 18.\n\n8. Pregnancy and postpartum history. Number of pregnancies, outcomes, dates, breastfeeding duration if applicable. Postpartum athletes carry different baseline body composition, ferritin, and energy-availability profiles than nulliparous athletes, and the postpartum window changes how the rest of the chart should be read.\n\nEight fields, every female-athlete intake. The structured interview takes 5-8 minutes to capture cleanly.\n\n## The interview structure\n\nThe athlete rarely volunteers everything she experiences. Three interview moves recover the gap.\n\nMove 1: The calendar approach. Ask the athlete to pull up her cycle-tracking app (Flo, Clue, Apple Health, Garmin Connect) and read the last three cycles directly off the screen. Self-recall is unreliable; the app data is structured. About 70-80% of female athletes under 35 are already tracking; for those who aren't, schedule a one-month follow-up to capture the first cycle prospectively.\n\nMove 2: The contraceptive specificity sweep. Don't accept "I'm on the pill." Ask: (1) Which brand? (2) Is it combined or progestin-only? (3) 21-day or 28-day pack? Extended-cycle? (4) When was it started? (5) Was it preceded by any other method? Brand specificity matters because the hormonal load varies meaningfully across formulations.\n\nMove 3: The energy-availability cross-check. Independently of the menstrual history, capture estimated energy intake and exercise energy expenditure. An athlete reporting "regular cycle" with calculated energy availability under 30 kcal/kg fat-free mass per day is a chart contradiction — the cycle is either tracked inaccurately, contraceptive-masked, or close to dysregulation. Document the contradiction and re-check.\n\n## The contraceptive cross-reference\n\nThe contraceptive method changes how every downstream biomarker should be read.\n\nCombined hormonal contraceptives (oral, patch, ring): suppress endogenous cycling and produce a withdrawal bleed. Bone-density acquisition during adolescent use is debated and likely reduced compared to natural cycling. Iron status is preserved or improved (lighter flow). Body-composition trends include a small fluid-retention component that DXA and BIA will both capture as a lean-mass overestimation early in use.\n\nProgestin-only methods (mini-pill, Depo-Provera, hormonal IUDs, implant): variable cycle expression. Depo-Provera specifically is associated with reversible bone-density loss and carries a black-box warning for use beyond two years. Hormonal IUDs typically reduce flow and improve iron status. The implant and mini-pill have variable bleed patterns that should not be read as "irregular cycle" — they are expected variation on the method.\n\nCopper IUD: preserves the natural cycle. Increases menstrual blood loss by an average of 20-50%. Iron-deficiency anemia risk is meaningfully elevated; ferritin and iron studies are baseline for any female athlete on a copper IUD.\n\nNo contraception: the natural cycle is observable and clinically informative. Cycle phase can be aligned with training load and nutrition planning. Cycle disruption is a direct signal of energy-availability inadequacy and bone-health risk.\n\nThe chart entry includes the method-specific interpretation note. The next reader of the chart knows how to read the ferritin, the DXA, the body-composition trend, and the energy-availability calculation in context.\n\n## Red flags that change the referral pathway\n\nFive patterns surface most often in the female-athlete intake; each triggers a documented chart flag and may trigger an outside-of-scope referral.\n\nPrimary amenorrhea past age 16. Refer to OB-GYN or adolescent medicine before continuing the nutrition workup. The cause needs medical workup before nutrition intervention.\n\nSecondary amenorrhea (3+ missed cycles) in an athlete not on hormonal contraception. This is the RED-S signature. Refer to sports medicine or OB-GYN for medical workup; in parallel, run the [low energy availability screening protocol](/blog/screening-athletes-for-low-energy-availability) and begin energy-availability restoration.\n\nOligomenorrhea (fewer than 9 cycles per year) in a non-contracepting athlete. Same pathway as secondary amenorrhea; less acute but the same RED-S concern.\n\nHeavy menstrual bleeding (subjective heavy, or quantitative >7 days / >80 mL). Refer to OB-GYN for workup; in parallel, order iron studies (ferritin, transferrin saturation, CBC) before assuming iron-deficiency anemia is purely dietary.\n\nPostpartum athlete returning to sport without postpartum medical clearance. The return-to-sport window after pregnancy has its own clinical guidelines (Goom et al. 2019, ACOG return-to-exercise guidance). The nutrition workup proceeds in parallel with — not in place of — postpartum medical clearance.\n\n## Where this lands in the SOAP\n\nThe Subjective section carries the cycle history in the athlete's own words. The Objective section carries the structured eight-field menstrual block, plus any related lab data the athlete brings (most commonly ferritin, hemoglobin, hematocrit, transferrin saturation, occasionally estradiol/FSH/LH if the athlete has been worked up by an endocrinologist).\n\nFormat I use for the Objective section:\n\n```\nMenstrual History:\n- Menarche: [age]\n- Cycles last 12 mo: [count]\n- Last three cycle lengths: [days, days, days; variation: X days]\n- Flow: [duration in days, intensity]\n- Current contraception: [specific product, start date]\n- Prior contraception: [list with rough dates]\n- Pregnancy history: [GxPx with dates and outcomes]\n- Method-specific interpretation note: [one sentence]\n```\n\nThe Assessment section integrates the menstrual history into the energy-availability picture and the iron-status picture explicitly. The Plan section documents any referrals being initiated and the cycle-aligned nutrition prescription if applicable.\n\n## Where this fits in the broader intake\n\nMenstrual-history charting pairs with three other intake components I have written about. The [pre-consult intake design](/blog/pre-consult-intake-design-for-sports-dietitians) captures the calendar-app data and the contraceptive product photo before session one. The menstrual block is one of the highest-priority inputs to [low energy availability screening](/blog/screening-athletes-for-low-energy-availability) — secondary amenorrhea in a non-contracepting athlete shifts the LEA screen from threshold-based to confirmed. And [body composition reports](/blog/body-composition-reports-as-bayesian-priors) on a female athlete cannot be read defensibly without the contraceptive method on file, because fluid retention from combined hormonal methods is a measurable component of the lean-mass and total-body-water signal.\n\nA documented menstrual history also changes how the [supplement reconciliation](/blog/supplement-reconciliation-in-sports-nutrition-intake) is interpreted. An iron supplement on a copper IUD makes clinical sense and may need a higher dose than label; the [iron-status workup](/blog/iron-status-workup-in-female-athletes) sets the dose against the staged depletion marker rather than guessing from the contraceptive method alone. An iron supplement on a hormonal IUD in an athlete with no documented deficiency is unnecessary load.\n\n## Common mistakes\n\nTreating "the athlete checked regular" as documentation. The checkbox is data capture; the chart entry needs the quantitative cycle history behind it.\n\nNot asking about the contraceptive method explicitly. Many female athletes don't volunteer it because they don't think it's relevant to nutrition. Ask directly, name the method specifically, document the product.\n\nReading "regular bleed" on a hormonal contraceptive as evidence of normal endogenous cycling. A withdrawal bleed is not a period. The endogenous cycle is suppressed. Functional hypothalamic amenorrhea can hide behind a contraceptive-induced withdrawal bleed indefinitely.\n\nSkipping the energy-availability cross-check. An athlete reporting a regular cycle and calculated energy availability under 30 kcal/kg FFM is a chart contradiction. Document and investigate.\n\nRe-reading the menstrual block only at intake. Cycle status changes. Contraception changes. Pregnancy happens. Re-check the menstrual history at every 90-day re-evaluation, or whenever a related biomarker shifts.\n\nFailing to capture the postpartum window. A postpartum athlete returning to sport six months out has a different baseline ferritin, body composition, and energy-availability profile than her pre-pregnancy chart. Document the postpartum status and adjust interpretation accordingly.\n\n## Where platform tooling helps\n\nThe bottleneck in menstrual-history charting is the structured capture and the calendar-app integration. Reading cycle data off the athlete's phone, transcribing the contraceptive product into the chart, calculating cycle variation, and surfacing the method-specific interpretation note are all repetitive structural work that consumes session time the RD should be spending on assessment.\n\nThe leverage is a structured female-athlete intake module that ingests calendar-app cycle data via athlete-controlled export (Apple Health, Garmin Connect, Strava, native integrations with Flo and Clue), cross-references the contraceptive method against an internal interpretation database, flags red-flag patterns automatically, and writes the eight-field block into the SOAP draft.\n\nThe RD's job becomes review and assessment, not transcription.\n\n## The bottom line\n\nMenstrual-history charting is one of the highest-yield, most-overlooked pieces of the female-athlete sports nutrition intake. It catches functional hypothalamic amenorrhea masked by hormonal contraception, identifies the copper-IUD athlete who needs aggressive iron monitoring, surfaces the secondary-amenorrhea athlete who needs a RED-S workup, and makes every downstream biomarker interpretable.\n\nIf your current intake captures menstrual status as a single checkbox, the chart is not documented. Add the eight-field structure, the contraceptive cross-reference, and the energy-availability cross-check, and the next reader of the chart will be able to tell what the female athlete in front of them is actually presenting.\n\n[Calsanova's Dietitian plan](/signup?role=dietitian) ships a female-athlete intake module with cycle-app integration (Apple Health, Garmin Connect, native Flo and Clue support), structured eight-field menstrual capture, a contraceptive product database with method-specific interpretation notes, automatic red-flag detection for primary and secondary amenorrhea, and a SOAP-ready menstrual block. Start your 30-day free trial and turn the menstrual-history question into a clinical record instead of a checkbox.
Ready to modernize your practice?
Calsanova gives dietitians AI-powered meal planning, food recognition, video consultations, and HIPAA-compliant infrastructure.
Start your free trialGet more like this.
Evidence-based writing on nutrition, performance, and the research behind what actually works. No spam, no daily emails — just the good stuff.
Written by Nelson Marques, MS, RD, LD — a registered dietitian and performance nutrition specialist. Founder of Calsanova. More about Nelson
More from the Classroom
Co-Treatment Documentation With Athletic Trainers: What the Sports RD Should Send, Receive, and Chart
Most sports dietitians work alongside athletic trainers on the same athletes — and most of those co-treatment relationships run on hallway conversations and group texts. Here is the documentation protocol that turns the AT-RD relationship into a clinical record both sides can defend, with the specific fields to capture and the cadence that keeps it working.
May 26, 2026
Iron-Status Workup in Female Athletes: The Ferritin → Transferrin Saturation → Reticulocyte Hemoglobin Protocol
Most labs flag iron deficiency only at the rickets-era hemoglobin threshold. By then the athlete has been performance-decremented for months. The fix is a three-marker primary panel — ferritin + transferrin saturation + reticulocyte hemoglobin — read against hs-CRP and the contraceptive method, with an every-other-day supplementation protocol that absorbs better than daily dosing.
May 28, 2026
Supplement Reconciliation in the Sports Nutrition Intake: A Clinical Documentation Protocol
Most sports nutrition intakes capture supplement use as a single free-text line. That isn't reconciliation — it's stenography. Here is the clinical protocol I use to chart every product an athlete is taking, with dose, form, third-party testing status, interaction risk, and a defensible plan recommendation.
May 21, 2026